Duality Advisers, LP Arvinas, Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021
SELL
$60.45 - $84.26 $620,458 - $864,844
-10,264 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$58.19 - $91.37 $597,262 - $937,821
10,264 New
10,264 $678,000
Q4 2020

Feb 09, 2021
SELL
$20.19 - $84.93 $733,906 - $3.09 Million
-36,350 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$22.99 - $36.34 $835,686 - $1.32 Million
36,350 New
36,350 $858,000

Others Institutions Holding ARVN

# of Institutions
230
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.06B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email